C

Chabiotech Co Ltd
KOSDAQ:085660

Watchlist Manager
Chabiotech Co Ltd
KOSDAQ:085660
Watchlist
Price: 10 740 KRW -27.73%
Market Cap: 604.8B KRW
Have any thoughts about
Chabiotech Co Ltd?
Write Note

Chabiotech Co Ltd
Net Issuance of Common Stock

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Chabiotech Co Ltd
Net Issuance of Common Stock Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Net Issuance of Common Stock CAGR 3Y CAGR 5Y CAGR 10Y
C
Chabiotech Co Ltd
KOSDAQ:085660
Net Issuance of Common Stock
â‚©38B
CAGR 3-Years
99%
CAGR 5-Years
-11%
CAGR 10-Years
-11%
No Stocks Found

Chabiotech Co Ltd
Glance View

Market Cap
604.8B KRW
Industry
Health Care

Cha Biotech Co., Ltd. engages in the research of cell therapy and storage of cord blood. The company is headquartered in Seoul, Seoul. The company went IPO on 2005-12-27. is a Korea-based company mainly engaged in the bio business. Along with its subsidiaries, the Company operates its business through two segments: bio segment and optical segment. Its bio segment engages in the provision of medical services; development of stem cells and cell therapy products; production of cosmetics and cosmetic raw materials; distribution of medical devices and others, as well as cord blood storage, health care services and others. Its optical segment engages in the manufacture of optical lenses, optical modules and other parts, which are used in mobile phone cameras.

Intrinsic Value
9 965.82 KRW
Overvaluation 7%
Intrinsic Value
Price
C

See Also

What is Chabiotech Co Ltd's Net Issuance of Common Stock?
Net Issuance of Common Stock
38B KRW

Based on the financial report for Sep 30, 2024, Chabiotech Co Ltd's Net Issuance of Common Stock amounts to 38B KRW.

What is Chabiotech Co Ltd's Net Issuance of Common Stock growth rate?
Net Issuance of Common Stock CAGR 10Y
-11%

Over the last year, the Net Issuance of Common Stock growth was 535%. The average annual Net Issuance of Common Stock growth rates for Chabiotech Co Ltd have been 99% over the past three years , -11% over the past five years , and -11% over the past ten years .

Back to Top